Manyun Dai

821 total citations · 1 hit paper
34 papers, 613 citations indexed

About

Manyun Dai is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Manyun Dai has authored 34 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Pharmacology and 11 papers in Molecular Biology. Recurrent topics in Manyun Dai's work include Drug Transport and Resistance Mechanisms (18 papers), Liver Disease Diagnosis and Treatment (8 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). Manyun Dai is often cited by papers focused on Drug Transport and Resistance Mechanisms (18 papers), Liver Disease Diagnosis and Treatment (8 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). Manyun Dai collaborates with scholars based in China, United States and Bahrain. Manyun Dai's co-authors include Fei Li, Qi Zhao, Frank J. Gonzalez, Aiming Liu, Julin Yang, Weifeng Zhu, Zhen Tan, Danjun Song, Yingmei Tang and Ting Zhang and has published in prestigious journals such as Nature Communications, International Journal of Molecular Sciences and British Journal of Pharmacology.

In The Last Decade

Manyun Dai

31 papers receiving 605 citations

Hit Papers

Parabacteroides distasonis ameliorates hepatic fibrosis p... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manyun Dai China 13 237 168 161 123 98 34 613
Krisztina Hagymási Hungary 17 233 1.0× 68 0.4× 120 0.7× 108 0.9× 75 0.8× 89 922
G Pisani Argentina 16 242 1.0× 90 0.5× 164 1.0× 85 0.7× 36 0.4× 41 749
Meiyu Jin China 15 366 1.5× 42 0.3× 216 1.3× 99 0.8× 69 0.7× 45 809
Sahar K. Hegazy Egypt 13 314 1.3× 82 0.5× 65 0.4× 77 0.6× 60 0.6× 36 695
Jae Hyeon Park South Korea 16 197 0.8× 77 0.5× 82 0.5× 83 0.7× 26 0.3× 33 570
Qionghui Huang China 16 328 1.4× 43 0.3× 89 0.6× 164 1.3× 57 0.6× 32 718
Ahmed Aref Egypt 13 136 0.6× 85 0.5× 38 0.2× 89 0.7× 93 0.9× 35 628
Zhongjian Wang China 16 204 0.9× 117 0.7× 94 0.6× 105 0.9× 13 0.1× 44 570

Countries citing papers authored by Manyun Dai

Since Specialization
Citations

This map shows the geographic impact of Manyun Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manyun Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manyun Dai more than expected).

Fields of papers citing papers by Manyun Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manyun Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manyun Dai. The network helps show where Manyun Dai may publish in the future.

Co-authorship network of co-authors of Manyun Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Manyun Dai. A scholar is included among the top collaborators of Manyun Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manyun Dai. Manyun Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Manyun, Peng Wan, Bin Zhang, et al.. (2025). Gut-vascular barrier mediated Tripterygium wilfordii-induced liver injury: the synergism between triptolide and celastrol via intestinal FXR-ET-1 pathway. Journal of Ethnopharmacology. 349. 119900–119900.
2.
Dai, Manyun, et al.. (2025). Triptophenolide aggravates triptolide-induced liver injury through disrupting the biological function of intestine. Toxicology and Applied Pharmacology. 500. 117354–117354.
3.
Dai, Manyun, et al.. (2024). A CDAHFD-induced mouse model mimicking human NASH in the metabolism of hepatic phosphatidylcholines and acyl carnitines. Food & Function. 15(6). 2982–2995. 7 indexed citations
4.
Zhang, Yimin, et al.. (2024). Oxidative balance score and the potential for suffering rheumatoid arthritis: a cross-sectional study. Frontiers in Immunology. 15. 1454594–1454594. 5 indexed citations
5.
Lin, Qiuxia, et al.. (2024). Aspirin Caused Intestinal Damage through FXR and ET-1 Signaling Pathways. International Journal of Molecular Sciences. 25(6). 3424–3424. 4 indexed citations
6.
Zhao, Qi, Manyun Dai, Jingyi Duan, et al.. (2023). Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice. Nature Communications. 14(1). 1829–1829. 125 indexed citations breakdown →
8.
Wan, Peng, et al.. (2023). Farnesoid X receptor regulators from natural products and their biological function.. PubMed. 43(3). 618–626. 7 indexed citations
9.
Zhang, Ting, et al.. (2023). Tripterygium wilfordii protects against an animal model of autoimmune hepatitis. Journal of Ethnopharmacology. 309. 116365–116365. 9 indexed citations
10.
Dai, Manyun, Liping Xu, Haoyue Zhang, et al.. (2022). Down-regulation of hepatic CLOCK by PPARα is involved in inhibition of NAFLD. Journal of Molecular Medicine. 101(1-2). 139–149. 4 indexed citations
11.
Dai, Manyun, Peng Wan, Ting Zhang, et al.. (2022). Metabolomics reveals the role of PPARα in Tripterygium Wilfordii-induced liver injury. Journal of Ethnopharmacology. 289. 115090–115090. 22 indexed citations
12.
Zhang, Ting, Manyun Dai, Bin Li, et al.. (2022). Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol. Molecules. 27(21). 7573–7573. 5 indexed citations
13.
Yan, Dongmei, Yikun Wang, Ting Zhang, et al.. (2021). Discovery of quality markers in Rubus Chingii Hu using UPLC-ESI-QTOF-MS. Journal of Pharmaceutical and Biomedical Analysis. 203. 114200–114200. 12 indexed citations
14.
Dai, Manyun, Xiaofang Ma, Xue‐Rong Xiao, et al.. (2021). Discovery and validation of quality markers of Fructus Aurantii against acetylcholinesterase using metabolomics and bioactivity assays. Journal of Separation Science. 44(11). 2189–2205. 11 indexed citations
15.
Dai, Manyun, et al.. (2020). Inhibition of inflammation by SP600125 in cholestatic liver injury is dependent on the administration‑based exposure profile. International Journal of Molecular Medicine. 46(6). 2271–2279. 2 indexed citations
16.
Dai, Manyun, Xiaowei Hu, Liping Xu, et al.. (2018). Basal PPARα inhibits bile acid metabolism adaptation in chronic cholestatic model induced by α-naphthylisothiocyanate. Toxicology Letters. 300. 31–39. 8 indexed citations
17.
Dai, Manyun, Julin Yang, Danjun Song, et al.. (2017). Inhibition of JNK signalling mediates PPARα‐dependent protection against intrahepatic cholestasis by fenofibrate. British Journal of Pharmacology. 174(18). 3000–3017. 41 indexed citations
18.
Song, Danjun, Manyun Dai, Shizhong Bu, et al.. (2016). PPARα-dependent increase of mouse urine output by gemfibrozil and fenofibrate. Canadian Journal of Physiology and Pharmacology. 95(2). 199–205. 1 indexed citations
19.
Tan, Zhen, Manyun Dai, Danjun Song, et al.. (2016). Dual action of peroxisome proliferator-activated receptor alpha in perfluorodecanoic acid-induced hepatotoxicity. Archives of Toxicology. 91(2). 897–907. 21 indexed citations
20.
Yang, Julin, Zhen Tan, Manyun Dai, et al.. (2016). Oral administration of nano-titanium dioxide particle disrupts hepatic metabolic functions in a mouse model. Environmental Toxicology and Pharmacology. 49. 112–118. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026